Not yet recruiting

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)

J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487

The purpose for this study is to see if the study drug, LY3484356, is safe and to determine what effects it has on breast cancer in participants with Estrogen Receptor Positive (ER+), HER2 Negative (HER2-) early stage (stage I-III) breast cancer, when given prior to surgery.
How long will I be in the trial?
Participation in this study could last up to 2.5 months.
Email
Not yet recruiting

A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)

J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487

The purpose for this study is to see if the study drug, LY3484356, is safe and to determine what effects it has on breast cancer in participants with Estrogen Receptor Positive (ER+), HER2 Negative (HER2-) early stage (stage I-III) breast cancer, when given prior to surgery.
How long will I be in the trial?
Participation in this study could last up to 2.5 months.
Email

Key Requirements

Age :

18+

Sex:

Female

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

Female

Participants must

Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer

Participants must be able to swallow capsules

Participants must be willing to be available for the duration of the study and are willing to follow study procedures

Participants must NOT

Participants must not be pregnant or breastfeeding

Participants must not plan to receive other treatment for breast cancer during study

Participants must not have major surgery within 28 days of starting study treatment

Trial Summary

Conditions the trial is for

Non-Metastatic Breast Cancer

What the trial is testing?

LY3484356

Could I receive a Placebo?

no

Enrollment Goal

60

Trial Dates

March 2021 - March 2022

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

Female

Participants must

Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer

Participants must be able to swallow capsules

Participants must be willing to be available for the duration of the study and are willing to follow study procedures

Participants must NOT

Participants must not be pregnant or breastfeeding

Participants must not plan to receive other treatment for breast cancer during study

Participants must not have major surgery within 28 days of starting study treatment

Trial Summary

Conditions the trial is for

Non-Metastatic Breast Cancer

What the trial is testing?

LY3484356

Could I receive a Placebo?

no

Enrollment Goal

60

Trial Dates

March 2021 - March 2022

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Non-Metastatic Breast Cancer Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?